Eloxx Pharmaceuticals, Inc. (ELOX) › Total LiabilitiesEloxx Pharmaceuticals, Inc. (ELOX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2011: $4.08M2012: $3.50M2013: $3.31M2014: $5.84M2015: $7.32M2016: $4.67M2017: $4.97M2018: $7.81M2019: $22.73M2020: $16.25M2021: $22.75M2022: $31.78M2023: $24.31M2024: $27.31M2025: $17.18M$17.18M2011Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$17.18M-37.1%2024$27.31M+12.3%2023$24.31M-23.5%2022$31.78M+39.7%2021$22.75M+40.1%2020$16.25M-28.5%2019$22.73M+191.2%2018$7.81M+57.0%2017$4.97M+6.6%2016$4.67M-36.3%2015$7.32M+25.3%2014$5.84M+76.5%2013$3.31M-5.4%2012$3.50M-14.2%2011$4.08M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share